Articles

Found results: 16338

Other life sciences

Not too "picky" enzyme

A new study provides a possible explanation for how one type of DNA damage leads to the development of cancer, diabetes, hypertension, cardiovascular and pulmonary diseases and Alzheimer's disease.

02.12.2014
Various

XVIII Russian Cancer Congress

From November 11 to 13, the XVIII Russian Cancer Congress was held in Moscow at the Congress Center of the World Trade Center.

02.12.2014
Other life sciences

HIV mutates and weakens, but the danger persists

Scientists emphasize that it will take a very long time before HIV becomes harmless, and before that happens, it is necessary to continue developing more effective drugs and affordable treatment to prevent the development of AIDS.

02.12.2014
Genetics

Our old friend ethanol

A person became addicted to alcohol long before he began to produce it, even long before he became a man. The ability to process ethanol originated in our ape-like ancestors 10 million years ago.

02.12.2014
Other life sciences

Three-dimensional model of the heart for cardiac surgeons

A life-size model of a particular patient's heart will allow the doctor to know in advance where to make an incision, how to redirect blood flow in the best way, as well as how to patch holes in the heart muscles.

01.12.2014
Biomedicine

Breast cancer: the offensive continues

Specialists from the Washington University Medical School in St. Louis conducted the first stage of clinical trials of a vaccine against metastatic breast cancer. Studies have shown the safety and effectiveness of the drug.

01.12.2014
Genetics

The tendency to violence is transmitted like hemophilia

The fact that genes make a significant contribution to a person's propensity for aggression is already known to science. Finnish scientists analyzed the involvement of specific genes in violent behavior in a large sample of criminal offenders.

01.12.2014
Genetic engineering

Gene therapy in Europe: the first swallow

Glybera is the first gene therapy drug in Western countries. It has already received approval in 2012, but final approval for its sale is expected by April next year.

01.12.2014
Genetics

Young and old genes in the human genome

On December 6, Konstantin Popadyin, a biologist and researcher at the Institute of Information Transmission Problems of the Russian Academy of Sciences, will speak as part of the Festival of Public Lectures #KNOW. The topic of the lecture is "Young and old genes in the human genome".

01.12.2014
Note to the businessman

V Congress of the National Association of Business Angels: results

The event, organized by the National Association of Business Angels with the support of RVC, brought together more than 150 participants: private investors, representatives of venture funds, large corporations, development institutions and authorities.

01.12.2014
Biomedicine

Breakthrough in the treatment of bladder cancer (and perhaps not only it)

The early results of the MPDL3280A clinical trial are so promising that the FDA has awarded it the status of breakthrough therapy, i.e. a drug for the treatment of life-threatening diseases, the higher effectiveness of which compared to traditional means has been proven by convincing clinical data.

01.12.2014
Other life sciences

GoBe: Russian "smart bracelet" – on sale soon

The first batch of HealBe GoBe will appear in Moscow in mid-December (at least, that's what the manufacturer promises). The approximate price is about 12 thousand rubles.

28.11.2014
Other life sciences

Genes, cells and biotechnologies: details

On the eve of the lecture on November 30, within the framework of the Festival of Public Lectures #KNOW correspondent "Polit.ru" spoke with the chief researcher of the Institute of General Genetics named afterVavilov by Sergey Kiselyov.

28.11.2014
Biomedicine

Evolution racing

Since the discovery of penicillin, mankind has been constantly conducting a kind of "arms race" with the world of bacteria. And, alas, today in this race we have begun to gradually lag behind the enemy...

28.11.2014
Cellular technologies

Stem cells for Nadal: a panacea or a risk?

Did one of the best tennis players of our time, Rafael Nadal Nadal, make a mistake by choosing stem cell treatment? Will medical technologies help Akinfeev, Yagudin and other athletes?

28.11.2014
Other life sciences

The first place was taken by two-hormone diabetes therapy

Researchers at the University of Montreal compared the effectiveness of three methods of treating type 1 diabetes: one- and two-hormone external "pancreas" with feedback and a conventional continuous insulin pump.

28.11.2014